Grünenthal Group announced that applications for the next EFIC–Grünenthal Grant cycle are closing soon.

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain. Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America and the US. Our products are available in approx. 100 countries. In 2025, Grünenthal employed around 4,100 people and achieved revenues of € 1.8 bn. More Information on www.grunenthal.com Jobs & Career: https://careers.grunenthal.com Imprint: https://www.grunenthal.com/imprint Privacy: https://www.grunenthal.com/privacy-statement This company profile is managed by Global Communications. In our commitment to transparency and the principles outlined in our digital ethics charter, Grünenthal wishes to inform you that generative artificial intelligence technologies are occasionally used to enhance content on this channel. Each content piece has been reviewed and edited by a team member before publication to ensure accuracy.